共 105 条
[42]
HULT K, 1979, APPL ENVIRON MICROB, V38, P772, DOI 10.1128/AEM.38.5.772-776.1979
[43]
Marked strain differences in the pharmacokinetics of an α4β1 integrin antagonist, 4-[1-[3-chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]methoxybenzoic acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism
[J].
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
2007, 320 (01)
:124-132
[46]
Kerkadi A, 1998, J TOXICOL ENV HEAL A, V53, P231, DOI 10.1080/009841098159367
[47]
Kontaxi M, 1996, J PHARMACOL EXP THER, V279, P1507
[48]
Kuiper-Goodman T, 1989, Biomed Environ Sci, V2, P179